Clinical Surgical Oncology (Sep 2024)
Chinese expert consensus on the pelvic exenteration for primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer
- Meng Zhuang,
- Yingchao Wu,
- Bin Tang,
- Jian Zhang,
- Tenghui Ma,
- Xicheng Wang,
- Yuan Tang,
- Yong Wu,
- Xin Wang,
- Xishan Wang,
- Jianqiang Tang,
- Wang Xishan,
- Wang Xin,
- Yu Xiangyang,
- Ma Tenghui,
- Wang Quan,
- Wang Gangcheng,
- Wang Ziqiang,
- Wang Zhigang,
- Wang Guiyu,
- Wang Gui Ying,
- Wang Xicheng,
- Deng Haijun,
- Bai Wenpei,
- Feng Bo,
- Bi Xiaogang,
- Zhu Yuping,
- Zheng Liu,
- Liu Haiyi,
- Liu Chao,
- Liu Qian,
- Tang Jianqiang,
- Xu Jianmin,
- Sun Yi,
- Sun Yue Ming,
- Du Binbin,
- Li Xinxiang,
- Li Zhengrong,
- Li Jun,
- Li Xue Song,
- Li Bo,
- Yang Chun Kang,
- Wu Xiaojian,
- Wu Bin,
- Qiu Jianguang,
- Tong Weihua,
- Zhang Wei,
- Zhang Jian,
- Chen Yinggang,
- Wu Aiwen,
- Wu Yingchao,
- Wu Yong,
- Lin Jianjiang,
- Ji Gang,
- Xiang Jianbin,
- Hu Gang,
- Yao Hongwei,
- Yuan Weitang,
- Peng Guo,
- Tang Yuan,
- Huang Ping,
- Ying Huang,
- Wen Bing,
- Xie Zhongshi,
- Zhuang Meng
Affiliations
- Meng Zhuang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
- Yingchao Wu
- Department of General Surgery, Peking University First Hospital, Beijing, China
- Bin Tang
- The First Department of General Surgery, Xiangtan Central Hospital, Hunan, China
- Jian Zhang
- Department of General Surgery, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China
- Tenghui Ma
- Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
- Xicheng Wang
- Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
- Yuan Tang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
- Yong Wu
- Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China
- Xin Wang
- Department of General Surgery, Peking University First Hospital, Beijing, China
- Xishan Wang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Corresponding author.
- Jianqiang Tang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Corresponding author.
- Wang Xishan
- Cancer Hospital, Chinese Academy of Medical Sciences, China
- Wang Xin
- Peking University First Hospital, China
- Yu Xiangyang
- Nankai Hospital, China
- Ma Tenghui
- The Sixth Affiliated Hospital of Sun Yat-sen University, China
- Wang Quan
- The First Hospital of Jilin University, China
- Wang Gangcheng
- Henan Province Cancer Hospital, China
- Wang Ziqiang
- West China Hospital, Sichuan University, China
- Wang Zhigang
- Shanghai Sixth People's Hospital, China
- Wang Guiyu
- The Second Affiliated Hospital of Harbin Medical University, China
- Wang Gui Ying
- The Second Affiliated Hospital of Hebei Medical University, China
- Wang Xicheng
- Peking University Cancer Hospital, China
- Deng Haijun
- Nanfang Hospital, Southern Medical University, China
- Bai Wenpei
- Shijitan Hospital, Capital Medical University, China
- Feng Bo
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
- Bi Xiaogang
- Shanxi Provincial People's Hospital, China
- Zhu Yuping
- Zhejiang Provincial Cancer Hospital, China
- Zheng Liu
- Cancer Hospital, Chinese Academy of Medical Sciences, China
- Liu Haiyi
- Shanxi Hospital, Cancer Hospital, Chinese Academy of Medical Sciences, China
- Liu Chao
- Sichuan Provincial Cancer Hospital, China
- Liu Qian
- Shanxi Hospital, Cancer Hospital, Chinese Academy of Medical Sciences, China
- Tang Jianqiang
- Cancer Hospital, Chinese Academy of Medical Sciences, China
- Xu Jianmin
- Zhongshan Hospital, Fudan University, China
- Sun Yi
- Tianjin People's Hospital, China
- Sun Yue Ming
- The First Affiliated Hospital of Nanjing Medical University, China
- Du Binbin
- Gansu Provincial People's Hospital, China
- Li Xinxiang
- Fudan University Cancer Hospital, China
- Li Zhengrong
- The First Affiliated Hospital of Nanchang University, China
- Li Jun
- The Second Affiliated Hospital of Zhejiang University School of Medicine, China
- Li Xue Song
- Peking University First Hospital, China
- Li Bo
- The Affiliated Hospital of Yunnan University, China
- Yang Chun Kang
- Fujian Provincial Cancer Hospital, China
- Wu Xiaojian
- The Sixth Affiliated Hospital of Sun Yat-sen University, China
- Wu Bin
- Peking Union Medical College Hospital, China
- Qiu Jianguang
- The Sixth Affiliated Hospital of Sun Yat-sen University, China
- Tong Weihua
- The First Hospital of Jilin University, China
- Zhang Wei
- Changhai Hospital Affiliated to the Naval Medical University, China
- Zhang Jian
- Changzheng Hospital Affiliated to the Naval Medical University, China
- Chen Yinggang
- Shenzhen Hospital, Cancer Hospital of the Chinese Academy of Medical Sciences, China
- Wu Aiwen
- Peking University Cancer Hospital, China
- Wu Yingchao
- Peking University First Hospital, China
- Wu Yong
- The Second Affiliated Hospital of Soochow University, China
- Lin Jianjiang
- The First Affiliated Hospital of Zhejiang University School of Medicine, China
- Ji Gang
- Xijing Hospital of the Air Force Military Medical University, China
- Xiang Jianbin
- Huashan Hospital Affiliated to Fudan University, China
- Hu Gang
- Cancer Hospital, Chinese Academy of Medical Sciences, China
- Yao Hongwei
- Beijing Friendship Hospital, Capital Medical University, China
- Yuan Weitang
- The First Affiliated Hospital of Zhengzhou University, China
- Peng Guo
- Peking University People's Hospital, China
- Tang Yuan
- Cancer Hospital, Chinese Academy of Medical Sciences, China
- Huang Ping
- Shaw Hospital, Nanjing Medical University, China
- Ying Huang
- Union Hospital of Fujian Medical University, China
- Wen Bing
- Peking University First Hospital, China
- Xie Zhongshi
- China-Japan Friendship Hospital, Jilin University, China
- Zhuang Meng
- Cancer Hospital, Chinese Academy of Medical Sciences, China
- Journal volume & issue
-
Vol. 3,
no. 3
p. 100053
Abstract
Pelvic exenteration is often required for primary rectal cancer beyond total mesorectal excision (PRC-bTME) and locally recurrent rectal cancer (LRRC). Some patients with radical resection can achieve long-term survival, but they need to face risks, such as huge surgical trauma, serious perioperative complications, permanent loss of organ function and decline in quality of life. Preoperative evaluation of PRC-bTME and LRRC should emphasize multidisciplinary collaboration and develop individualized diagnosis and treatment strategies. The principles of function preservation and risk-benefit balance in surgery oncology should be followed, and R0 resection should be emphasized. Perioperative complications, surgical trauma and organ function loss should be minimized to achieve the best quality control and balance point. This consensus was formulated by the Colorectal Cancer Committee of the Chinese Medical Doctor Association and the Gastrointestinal Surgery Committee of China International Exchange and Promotive Association for Medical and Health Care. The draft was formed based on the summary of domestic and foreign research progress and expert experience. After discussion, review and modification by experts, an anonymous voting was conducted for each major opinion, and in-depth verification was carried out according to the principles of evidence-based medicine. Finally, the Chinese expert consensus on the pelvic exenteration with primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer (2023 edition) was formed. This consensus mainly summarizes the indications and contraindications of pelvic exenteration (PE) for PRC-bTME and LRRC, preoperative diagnosis and evaluation, perioperative treatment, as well as the resection scope, surgical methods, reconstruction of related organs, safety and complications of PE, postoperative follow-up and other issues, in order to provide guidance for PE in patients with PRC-bTME and LRRC.